Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR627429

GTEX

966301fa-1215-5eee-ab43-30a1eb21a713

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Female

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • SPERMATOGENESIS+0.193
  • UV_RESPONSE_DN+0.150
  • KRAS_SIGNALING_DN+0.121
  • MITOTIC_SPINDLE+0.107
  • G2M_CHECKPOINT+0.087
  • PROTEIN_SECRETION-0.013
  • PANCREAS_BETA_CELLS-0.078
  • ANDROGEN_RESPONSE-0.079
  • BILE_ACID_METABOLISM-0.088
  • APICAL_SURFACE-0.121

Top 10 suppressed

  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.527
  • OXIDATIVE_PHOSPHORYLATION-0.510
  • INTERFERON_ALPHA_RESPONSE-0.473
  • MYC_TARGETS_V2-0.452
  • MYC_TARGETS_V1-0.451
  • ADIPOGENESIS-0.443
  • TNFA_SIGNALING_VIA_NFKB-0.439
  • DNA_REPAIR-0.436
  • APOPTOSIS-0.426
  • UV_RESPONSE_UP-0.424

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR627451
brain-umap@2
GTEX0.990
2SRR627462
brain-umap@2
GTEX0.986
362454053-936d-4f19-8522-6219c47bdd1c
colon-landscapes@1
0.953
4e356598b-7611-492a-98ed-ef2ec1b77b7a
colon-landscapes@1
0.951
5SRR627455
brain-umap@2
GTEX0.949
6ed8896f8-24ef-43a4-ace6-ed9353bd11c2
colon-landscapes@1
0.948
7b8135e73-31c3-49af-b4da-a7ed5f28d68a
colon-landscapes@1
0.941
8SRR1455060
brain-umap@2
GTEX0.936
9SRR627299
brain-umap@2
GTEX0.928
10TCGA-A7-A0DB-01C-02R-A277-07
breast-umap@18
D0.922

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 5 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
SPERMATOGENESIS0.193Inavolisib— uncovered
UV_RESPONSE_DN0.150Inavolisib— uncovered
KRAS_SIGNALING_DN0.121Remibrutinib— uncovered
MITOTIC_SPINDLE0.107Inavolisib— uncovered
G2M_CHECKPOINT0.087Inavolisib— uncovered